# HIV and Malignancy Scientific Working Group

> **NIH NIH P30** · HARVARD UNIVERSITY · 2024 · $49,187

## Abstract

PROJECT SUMMARY/ABSTRACT: 
The overall goal of the HU CFAR HIV & Malignancy Scientific Working Group (SWG) is to address this growing burden of malignancies among PLWH by 1) engaging community partners, clinicians, and scientists; 2) facilitating clinical and specimen data synthesis and interpretation; and 3) supporting investigators, especially Early Career Investigators (ECIs). Through these activities, we will accelerate the discovery of mechanisms and interventions to prevent and treat cancers among PLWH. A key theme through these three aims is catalyzing translational research and identifying priorities at each translational stage, and guiding the process to ultimately have an impact on individual and population-level health. The HU CFAR is uniquely positioned to leverage experts, clinical and basic science resources, and data and specimens to address scientific questions about HIV and malignancies

## Key facts

- **NIH application ID:** 10895894
- **Project number:** 2P30AI060354-21
- **Recipient organization:** HARVARD UNIVERSITY
- **Principal Investigator:** Ruanne Vanessa Barnabas
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $49,187
- **Award type:** 2
- **Project period:** 2004-07-01 → 2029-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10895894

## Citation

> US National Institutes of Health, RePORTER application 10895894, HIV and Malignancy Scientific Working Group (2P30AI060354-21). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10895894. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*